We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

22 hedge funds and large institutions have $9.55M invested in Vaxart in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

614% more capital invested

Capital invested by funds: $1.34M → $9.55M (+$8.21M)

155.68% more ownership

Funds ownership: 12.51% → 168.2% (+156%)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

5% more funds holding

Funds holding: 21 → 22 (+1)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$15.7M
2
SM
Sabby Management
Florida
+$181K
3
Renaissance Technologies
Renaissance Technologies
New York
+$148K
4
UBS Group
UBS Group
Switzerland
+$60.7K
5
Citadel Advisors
Citadel Advisors
Florida
+$56.3K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$36.6K
2
SXL
Summit X LLC
Missouri
-$18K
3
Goldman Sachs
Goldman Sachs
New York
-$13K
4
VF
Virtu Financial
New York
-$4.59K
5
Morgan Stanley
Morgan Stanley
New York
-$168
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$8.62M +$15.7M +24,000,000 New
SM
2
Sabby Management
Florida
$430K +$181K +277,063 +30%
Renaissance Technologies
3
Renaissance Technologies
New York
$347K +$148K +226,300 +31%
UBS Group
4
UBS Group
Switzerland
$39K +$60.7K +92,978 +636%
Citadel Advisors
5
Citadel Advisors
Florida
$31K +$56.3K +86,221 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$16K – – –
BlackRock
7
BlackRock
New York
$15K – – –
Carson Wealth (CWM LLC)
8
Carson Wealth (CWM LLC)
Nebraska
$15K – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$12K -$36.6K -55,987 -63%
VF
10
Virtu Financial
New York
$10K -$4.59K -7,036 -20%
CCM
11
Carlson Capital Management
Minnesota
$10K – – –
RFWA
12
RPg Family Wealth Advisory
Massachusetts
$3.59K – – –
PA
13
Parallel Advisors
California
$2K +$4.51K +6,901 New
PNC Financial Services Group
14
PNC Financial Services Group
Pennsylvania
$1K – – –
Victory Capital Management
15
Victory Capital Management
Texas
$1K +$1.41K +2,165 New
RE
16
RBC Europe
United Kingdom
$252 – – –
SXL
17
Summit X LLC
Missouri
– -$18K -26,400 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$13K -19,616 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$168 -258 -27%
IA
20
IFP Advisors
Florida
– +$106 +162 New

VXRT Hedge Fund Activity: Q3 2019 in Review

22 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2019, worth a combined $9.55M — up 614% from $1.34M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new VXRT positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $15.7M. The largest seller was Vanguard Group, cutting an estimated $36.6K.

  • 22 institutional investors held Vaxart (VXRT) as of Q3 2019, up from 21 in Q2 2019.
  • Funds reported $9.55M of Vaxart stock for Q3 2019, up 614% quarter-over-quarter.
  • 5 funds opened new Vaxart positions in Q3 2019 and 4 closed out, a net change of +1 holder.
  • The largest Vaxart buyer in Q3 2019 was Armistice Capital, an estimated $15.7M added.
  • The largest Vaxart seller in Q3 2019 was Vanguard Group, an estimated $36.6K sold.

Based on aggregated 13F filings for Q3 2019.